Amphastar Announces FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the…
European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 December 2025, approved the reclassification of fluticasone…
The herb linked to better memory, lower anxiety and Alzheimer’s protection
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
‘The role of Ozempic isn’t just about reduced consumption, it’s about a shift in values’
Weight loss medications are quietly reshaping how and why people drink, pushing alcohol towards a more selective and…
The holiday herb that can ease bloating and soothe muscles
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
Blood pressure medication recalled for potential cross-contamination, reports say
(Gray News) – Blood pressure medicine has been recalled because it may be cross-contaminated with another medication, according…
Surprising Ozempic Side Effects Doctors Want Women To Know
Surprising Ozempic Side Effects Doctors Want Women To Know | Woman’s World Use left and right arrow keys…
‘I turned to Mounjaro after receiving online hate and now I feel 20 years younger’
Labour MP Carolyn Harris said she didn’t want people to look at her when she entered a room,…
Check your medicine cabinets! Here’s 4 recalls you need to know for this week
Every recall represents more than a headline — it’s a potential crisis averted. December’s list of food and…
Critical Recall Alert: Nasal Spray Linked to Life-Threatening Infections |
A popular nasal spray, ReBoost, has been voluntarily recalled nationwide by MediNatura New Mexico Inc. due to potential…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…